2018
Development and Validation of LC–MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma
Nassar AF, Wisnewski AV, Wu T, Lam TT, King I. Development and Validation of LC–MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma. Journal Of Chromatographic Science 2018, 57: 195-203. PMID: 30395213, DOI: 10.1093/chromsci/bmy100.Peer-Reviewed Original Research
2010
Case Study: The Unanticipated Loss of N2 from Novel DNA Alkylating Agent Laromustine by Collision‐Induced Dissociation: Novel Rearrangements
Nassar A, Du J, Roberts D, Lin K, Belcourt M, King I, Lam T. Case Study: The Unanticipated Loss of N2 from Novel DNA Alkylating Agent Laromustine by Collision‐Induced Dissociation: Novel Rearrangements. 2010, 217-228. DOI: 10.1002/9780470890387.ch5.ChaptersCase Study: Identification of in vitro Metabolite/Decomposition Products of the Novel DNA Alkylating Agent Laromustine
Nassar A, Du J, Roberts D, Lin K, Belcourt M, King I, Lam T. Case Study: Identification of in vitro Metabolite/Decomposition Products of the Novel DNA Alkylating Agent Laromustine. 2010, 229-244. DOI: 10.1002/9780470890387.ch6.Chapters